Diaclone ELISpot assays, tried and trusted by researchers worldwide
Publication date : 2021-04-01
Diaclone ELISpots (Enzyme-Linked Immunospot Assays) are highly specific immunoassays for the analysis of cytokine and other soluble molecule production and secretion from T-cells at a single cell level in conditions closely comparable to the in-vivo environment with minimal cell manipulation.
Our BEST SELLER the IFNγ ELISpot assay, is widely used in clinical cancer studies and also in COVID-19 research.
Diaclone, Medix Biochemica group: more than 35 years of expertise in Immuno-oncology Publication date : 2023-01-06
Discover how the Diaclone team, and their excellent scientific knowhow can help you in your precious research projects.
Read more
What's New at Diaclone? Publication date : 2022-12-06
A continuous and high-level Research & Development activity to match the needs of our customers and supply the best products...
Read more
For ELISpot choose Diaclone! Publication date : 2022-09-07
Our experience and innovation at your service....
Read more
Bioresource Technology joins Medix Biochemica Group Publication date : 2022-07-07
Medix Biochemica broadens its capabilities in diagnostic base matrices through the acquisition of Bioresource Technology
Read more
CE certified product range Publication date : 2022-05-25
Important news concerning our CE Marked product range...
Read more
Support and tools for COVID-19 Research Publication date : 2021-12-17
We provide a wide selection of SARS-CoV-2 antibodies and recombinant proteins to support COVID-19 related assay development.
We are actively working to develop a recombinant SARS-CoV-2 Spike RBD Omicron variant protein and it will be available very soon!
Read more
New! Anti-SARS-CoV-2 RBD domain Neutralizing Antibodies Publication date : 2021-11-03
Our SARS-CoV-2 product range is extended with three anti-RBD (spike protein) "B-" Clones : B-B60, B-D69 and B-R41
Read more
Now available - SARS-CoV-2 Spike RBD Variant Delta Publication date : 2021-07-27
Developed in our laboratories in Besançon (France)
#715-H25-0BU SARS-CoV-2 Spike RBD Variant Delta Lineage B.1.617.2
Read more
Medix Biochemica expands its monoclonal antibody offering through the acquisition of Diaclone Publication date : 2021-07-13
Medix Biochemica has acquired 100 percent of the shares of Diaclone, a prominent provider of monoclonal antibodies in the areas of inflammation, oncology and immunology.
Read more
ELISpot Kits - A new format to meet your demands Publication date : 2021-02-25
The Diaclone ELISpot kit range is extended with a new 2 PLATE FORMAT
Read more
Monoclonal Antibody Platform Publication date : 2021-02-05
Diaclone and Seed Biosciences collaborate on the development of a new workflow for a faster and more efficient antibody development process
Read more
NEW!... RECOMBINANT HUMAN SARS-CoV-2 PROTEINS Publication date : 2020-10-15
Developed in our laboratories in Besançon (France)
Read more
Anti-S1 Domain Spike Protein is now available at Diaclone Publication date : 2020-08-03
What you need to know about Exosomes Publication date : 2020-07-01
“Huge opportunities”. “Many hurdles”. “Enormous potential”....
Read more
Fast track your Covid-19 Research with Diaclone’s CYTOKINES Publication date : 2020-05-18
Essential tools for Cytokine Storm monitoring & Immunotherapy development...
Read more
Essential tools for COVID-19 and Immunotherapy research Publication date : 2020-04-02
Diaclone provides a large panel of research tools, Monoclonal Antibodies and Immunoassays, for measuring the levels of released cytokines triggered by viral infection (cytokine release syndrome - CRS), including a complete range of human IL-6 and TNF-α products.
Read more
Human IL-6 cytokine, a useful tool for Coronavirus disease (COVID-19) and Immunotherapy research Publication date : 2020-03-20
DIACLONE provides a large panel of products for the quantification of human IL-6 and other human cytokines.
Read more
Discover Diaclone ELISpot Publication date : 2020-02-06
Use Diaclone’s Toolbox to monitor your CAR-T cell responses Publication date : 2019-12-16
In vitro studies with Diaclone’s Toolbox to monitor the risks linked to immunotherapy....
Read more
Diaclone's Toolbox for your Car-T Development Publication date : 2019-11-12
Our Monoclonal Antibodies and ELISpot range are valuable tools for your CAR-T research.
Read more
Use Diaclone’s expertise to further characterize your antibody... Publication date : 2019-10-28
The Octet technology is fully integrated into our custom monoclonal antibody development so that it can be implemented to further study monoclonal antibody candidates.
Read more
CAR-T development Publication date : 2019-10-01
How can Diaclone support your CAR-T development?
Read more
DIACLONE Assays for the Human IL-17 Family Publication date : 2019-08-28
Diaclone has developed a large range of ELISA and ELISpot kits for the detection of Human IL-17A, IL-17F and IL-17A/F.
Read more
The CAM family: A new target for monitoring or treating cancers? Publication date : 2019-08-28
The cell adhesion molecules (CAMs) family includes more than 50 proteins with four main groups: immunoglobulin (Ig)-like CAMs, cadherins, selectins, and integrins.
Read more
